J&J Ordered to Pay $14M in Pelvic Mesh Lawsuit
A jury in Philadelphia docked Ethicon, a subsidiary of Johnson & Johnson, $14m in a case regarding its pelvic mesh products.
About the Trial Against Johnson & Johnson
According ot MassDevice, Sharon Carlino, the plaintiff in the case, was awarded $3.5 million in compensatory damages and $10 million in punitive damages.
The jury found that the transvaginal polypropylene tape implanted during the plaintiff’s 2005 hysterectomy was defective and Ethicon did not properly advise of the risks associated. She needed three surgeries to remove the mesh that had eroded.
Late last year, a similar case in the same court added $7 million in punitive damages to the $5.5 million in compensatory damages against Ethicon.
Ethican spokeswoman, Samantha Lucas, believes they have a strong ground for appeal.
Statistics on Defective Medical Devices
- In 2013, the U.S. food and Drug Administration (FDA) 63 high-risk devices. This represents an alarming increase of 350% compared to only five years prior.
- Between 2008 and 2011, 45% of medical device recalls involved due manufacture defects.
- 29% medical devices recalled between 2008 and 2011 malfunctioned during use or failed to provide intended results.
- Between 2005 and 2010, regulators received more than 4,000 reports of complications that were linked to transvaginal mesh devices..
- In the statement made by the FDA in 2011, it was suggested that transvaginal mesh devices were not as effective an option as traditional procedures used to treat pelvic organ prolapse and stress urinary incontinence. In addition to being less effective, they carried a far greater risk of injury.